SCHEMBL24309810

SCHEMBL24309810

CN1CCN(c2cccc(Oc3nc(NSc4cnn(C)c4)nc(Cl)c3C(F)(F)F)c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CTSC P53634 4/20 0.47
▸ EGFR P00533 16/20 0.41
▸ JAK2 O60674 2/20 0.38
▸ BLK P51451 2/20 0.38
▸ BMX P51813 2/20 0.38
▸ JAK3 P52333 2/20 0.38
▸ NUAK1 O60285 2/20 0.37
▸ NUAK2 Q9H093 2/20 0.37
▸ PLK4 O00444 1/20 0.36
▸ GAK O14976 1/20 0.36
▸ FLT3 P36888 1/20 0.36
▸ PTK2 Q05397 1/20 0.36
▸ BTK Q06187 1/20 0.36
▸ ITK Q08881 1/20 0.36
▸ ERBB4 Q15303 1/20 0.36
▸ DCLK3 Q9C098 1/20 0.36
▸ EML4 Q9HC35 1/20 0.36
▸ EIF2AK4 Q9P2K8 1/20 0.36
▸ ALK Q9UM73 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309843 0.86 CTSC (0.41) CTSCEGFRJAK2JAK3PTK2
SCHEMBL24310413 0.85 CTSC (0.35) CTSCEGFRPTK2
SCHEMBL24309808 0.83 CTSC (0.46) CTSCEGFRJAK2BLKBMX
SCHEMBL29566696 0.83 CTSC (0.46) CTSCEGFRJAK2BLKBMX
SCHEMBL24309916 0.80 EGFR (0.39) CTSCEGFRJAK2BLKBMX
SCHEMBL24310392 0.80 MAP4K1 (0.35) CTSCPTK2
SCHEMBL24310153 0.80 CTSC (0.36) CTSCEGFRJAK2BLKBMX
SCHEMBL24309648 0.78 CDK1 (0.34) —
SCHEMBL24310106 0.78 DRD2 (0.34) CTSCEGFRPTK2
SCHEMBL24310715 0.75 CSF1R (0.35) CTSCEGFRJAK2JAK3PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback